FDA Inspection
ImpactLifeImpactLife – FDA Inspection, Oct 6, 2017
Record Details
This FDA Inspection record concerns ImpactLife, with an inspection on October 6, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 70a0b0b7-7c21-4f02-b7a1-351e91850635
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1030109
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of ImpactLife
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 30, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 19, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 9, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 5, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 3, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ImpactLife
- FDA Inspection 1240356 - 2024-05-30
- FDA Inspection 1114603 - 2019-12-19
- FDA Inspection 948008 - 2015-10-09
- FDA Inspection 854420 - 2013-11-05
- FDA Inspection 776356 - 2012-04-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.